Insurance

A key Medtrade 2026 panel led by Synapse Health will unite industry leaders to chart the future of value-based care in the DME market.

A new data partnership aims to reveal the full financial toll of climate change, bridging the critical gap between insurance and finance for the first time.

For the 5th year, Mindr proves family-first policies aren't just good ethics—they're a powerful strategy for talent, retention, and bottom-line growth.

Beyond insurance, Superior HealthPlan invested nearly $1.2 million in 2025, opening a Uvalde health center and tackling youth mental health across Texas.

Generali Global Assistance consolidates its US and Canadian operations under new leadership, aiming for dominance in a booming post-pandemic travel market.

Spot's milestone highlights a major trend: as vet costs rise, pet insurance is becoming a crucial financial tool for American families and their pets.

After four years of profitable, bootstrapped growth, insurtech mea Platform lands a $50M investment to accelerate its mission of overhauling global insurance.

Nearly half of UK couples struggle with hearing loss, eroding intimacy. A new campaign reveals why a hearing check may be more romantic than any gift.

New research reveals the UK's booming sauna culture is more than just heat; it's a powerful social tool that could be prescribed to combat loneliness.

Mark Hunt, the architect of SIM's rise to an $86B powerhouse, has stepped down, leaving questions about the future of the firm he built from the ground up.

With 15+ years on the front lines, new DOMAC leader Monica Trimble plans to elevate the role of dental office managers through national certification.

Blue Cross divests its profitable insurance arm to Enstar Group, a move to bolster its core healthcare mission amid rising costs and industry shifts.

A new online pharmacy is challenging the 'prescribe and forget' model for weight loss drugs, offering integrated clinical care to combat safety concerns.

Iterum Therapeutics secures key Medicare access for its antibiotic ORLYNVAH™, but a costly FDA trial requirement for a new use casts a shadow on its future.

Essent Group boosts its dividend after a strong 2025, returning $700M to shareholders while making a strategic leap into the global P&C reinsurance market.

STADA and Bio-Thera's new golimumab biosimilar wins European approval, promising to slash healthcare costs and expand treatment access for millions.

Deep in China's interior, Chongqing's Yuzhong district is using a new trade corridor to attract global giants and reshape life, one container at a time.

Canada's largest P&C insurer swaps old debt for new capital, a strategic move to cut costs, enhance flexibility, and fuel its global expansion strategy.

With a record 21st NMMA CSI Award, Tigé Boats isn't just winning trophies; it's redefining long-term owner loyalty in the competitive marine industry.

The pet insurance giant swung to a major profit in 2025, but a closer look reveals a complex strategy of focused growth and rising acquisition costs.